资讯
21 小时on MSN
A University of Pennsylvania biotechnology company that aims to treat autoimmune diseases by reengineering cells within the ...
1 天
News-Medical.Net on MSNLeukemia-on-a-chip offers breakthrough in personalized cancer treatmentA team of researchers led by NYU Tandon School of Engineering's Weiqiang Chen has developed a miniature device that could ...
Clinical application: Treatment in a mouse model with milciclib in combination with mirvetuximab significantly reduced tumor ...
The acquisition will expand AbbVie's exploration of in vivo CAR-T therapy, an ambitious approach that could sidestep some of ...
Researchers use targeted lipid nanoparticles loaded with mRNA to reprogram T cells to fight autoimmune diseases ...
7 天
GlobalData on MSNGilead eyes Kymera’s ‘adhesive’ cancer drug in $750m dealKymera’s programme focuses on removing CDK2 from cells compared to other therapies that target the protein’s inhibition.
A nanoneedle patch painlessly extracts molecular data, offering a safer, repeatable alternative to traditional biopsies for ...
Bladder cancer, often misunderstood, affects both men and women, not just the elderly. While smoking is a significant risk ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果